ADIPOQ and neoplasm: These miRNAs are both consistently and substantially dysregulated in CRC and target upstream components of the adiponectin cascade, which suggests they impact oncogenesis (upregulated miRNAs) and tumor suppression (downregulated miRNAs) by virtue of adiponectin signaling regulation, placing them as viable candidates for future experimental work and potential biomarkers for disease management.